Keros Therapeutics, Inc. (KROS)
17.91
-0.08
(-0.44%)
USD |
NASDAQ |
Jan 30, 16:00
17.88
-0.03
(-0.17%)
After-Hours: 20:00
Keros Therapeutics Total Liabilities (Quarterly) : 39.20M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| MannKind Corp. | 539.19M |
| Sarepta Therapeutics, Inc. | 2.173B |
| Insmed, Inc. | 1.415B |
| Ionis Pharmaceuticals, Inc. | 2.415B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 742.78M |
| Shareholders Equity (Quarterly) | 703.58M |
| Debt to Equity Ratio | 0.0248 |
| Current Ratio | 29.86 |
| Net Debt Paydown Yield | -0.11% |